Merck Defends Right Not To Publish Clinical Trials
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck believes clinical trial disclosure rules must distinguish between hypothesis-generating and hypothesis-testing trials.
You may also be interested in...
Medical Journals To Require Registration Of All Controlled Trials On ClinicalTrials.gov
The International Committee of Medical Journal Editors will require that studies be registered at or before patient enrollment in order to be considered for publication. A Sept. 9 editorial notes that only ClinicalTrials.gov currently fits ICMJE registry criteria.
Medical Journals To Require Registration Of All Controlled Trials On ClinicalTrials.gov
The International Committee of Medical Journal Editors will require that studies be registered at or before patient enrollment in order to be considered for publication. A Sept. 9 editorial notes that only ClinicalTrials.gov currently fits ICMJE registry criteria.
Medical Journals To Propose Making Trial Registry Condition For Publication
International Committee of Medical Journal Editors will publish an editorial Sept. 9 proposing to make clinical trial registration a prerequisite for later publication. Merck exec highlights concerns with “assumption of...surreptitious behavior” that is behind the proposal.